Authors: GREIM G ESKENS F HOPPENER F BARBET NC CHOI L HANAUSKE AR VERWEIJ J BRUNTSCH U

Citation: G. Greim et al., PHASE-I TOLERABILITY - PHARMACOLOGICAL STUDY OF CGP48664, A NOVEL POLYAMINE BIOSYNTHESIS INHIBITOR, GIVEN IV ONCE WEEKLY X 4 (Q 6 WKS) TO PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 443-443

Authors: BOWMAN A TWELVES C HOEKMAN K SIMPSON A SMYTH J VERMORKEN J HOPPENER F BEIJNEN J VEGA E JIMENO J HANAUSKE AR

Citation: A. Bowman et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS, Annals of oncology, 9, 1998, pp. 452-452

Authors: HILLEBRAND MJX JIMENO J CVITKOVIC E HOEKMAN K HOPPENER F TWELVES C VILLALONA M ROSING H BEIJNEN JH

Citation: Mjx. Hillebrand et al., PHARMACOKINETICS OF ECTEINASCIDIN-743 (ET-743) IN 3 PHASE-I STUDIES, Annals of oncology, 9, 1998, pp. 455-455

Authors: AWADA A THODTMANN R PICCART MJ DIEU M BARTHOLOMEUS S HOPPENER F WANDERS J VONBROEN IM HANAUSKE AR

Citation: A. Awada et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF LU-79553 ADMINISTEREDEVERY 21 OR 42 DAYS IN PATIENTS (PTS) WITH SOLID TUMORS - AN EORTC-ECSG STUDY, Annals of oncology, 9, 1998, pp. 470-470

Authors: THODTMANN R AWADA A PICCART M HOPPENER F WANDERS J VONBROEN IM HANAUSKE AR

Citation: R. Thodtmann et al., CLINICAL AND PHARMACOKINETIC EVALUATION OF THE NEW BISNAPHTALAMIDE LU-79553 ADMINISTERED EVERY 21 DAYS IN PATIENTS WITH SOLID TUMORS - AN EORTC ECSG STUDY/, European journal of cancer, 33, 1997, pp. 1106-1106

Authors: TWELVES CJ VERMORKEN J BOWMAN A SIMPSON A SMYTH J HOPPENER F BEIJNEN J JIMENO J HANAUSKE AR

Citation: Cj. Twelves et al., PHASE-I AND PHARMACOKINETIC STUDY OF ECTEINASCIDIN-743 (ET-743) GIVENAS A ONE-HOUR INFUSION EVERY 21 DAYS, European journal of cancer, 33, 1997, pp. 1107-1107